Avidity Partners Management LP 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-19 9:30 pm Purchase |
2025-03-17 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 3,378,939 9.900% |
448,689 (+15.31%) |
Filing |
| 2024-12-03 9:19 pm Purchase |
2024-11-29 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 2,930,250 9.900% |
7,427 (+0.25%) |
Filing |
| 2024-01-31 12:11 pm Purchase |
2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH |
Avidity Partners Management LP | 2,922,823 9.900% |
2,922,823 (New Position) |
Filing |